CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance
Abstract Most genetic alterations that drive melanoma development and resistance to targeted therapy have been uncovered. In contrast, and despite their increasingly recognized contribution, little is known about the non‐genetic mechanisms that drive these processes. Here, we performed in vivo gain‐...
Saved in:
| Main Authors: | Arthur Gautron, Laura Bachelot, Marc Aubry, Delphine Leclerc, Anaïs M Quéméner, Sébastien Corre, Florian Rambow, Anaïs Paris, Nina Tardif, Héloïse M Leclair, Oskar Marin‐Bejar, Cédric Coulouarn, Jean‐Christophe Marine, Marie‐Dominique Galibert, David Gilot |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2021-03-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202013466 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The AhR‐SRC axis as a therapeutic vulnerability in BRAFi‐resistant melanoma
by: Anaïs Paris, et al.
Published: (2022-10-01) -
Recent advances in transition-metal-free arylation reactions involving hypervalent iodine salts
by: Ritu Mamgain, et al.
Published: (2024-11-01) -
Advances in α-Arylation of Carbonyl Compounds: Diaryliodonium Salts as Arylating Agents
by: Xiao-Wei Chen, et al.
Published: (2025-07-01) -
Catalytic pathways for N-arylation of benzimidazoles: A comprehensive review
by: Anila Ghulam, et al.
Published: (2025-01-01) -
An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
by: Morgane Morabito, et al.
Published: (2019-07-01)